Based on the expression, clinical outcome results and the enzyme activity to catalyse tryptophan to kynurenine, IDO1 may act as a more important role in tumour, so we choose IDO1 as the protagonist of the follow‐up analysis. This evidence concerns the gene IDO1 and neoplasm.